In line with this, we found that controlling the expression of CD133 did not impact SORT1 expression or Notch signaling, indicating that CD133 is a downstream component regulated by SORT1 in HCC (Supplementary Fig. 3G, H). This evidence concerns the gene SORT1 and hepatocellular carcinoma.